National Legislative Association on Prescription Drug Prices Resolution Opposing the Inclusion of a Pharmaceuticals Chapter in the Trans Pacific Partnership
January 24th, 2011
The resolution calls on the U.S. to halt the use of trade agreements to enact international disciplines on pharmaceutical pricing programs. It was passed at the winter meeting of the National
Legislative Association on Prescription Drug Prices, an organization of
state legislators that work on health issues.
specifically targets the ongoing negotiation of the Trans-Pacific
Partnership (TPP), a plurilateral trade agreement among eight nations.
To date, no negotiating text has been publicly released. But the branded
drug lobby has requested the inclusion of a chapter in the agreement
that would require countries to “appropriately recognize the value of
patented medicines“ in public drug reimbursement programs and provide
appeals for drug manufactures to challenge listing and reimbursement
decisions of public health authorities.